Schonfeld Strategic Advisors LLC - Significant Ownership

Signature - Title
Mark Peckman - General Counsel and Chief Compliance Officer
Location
New York, NY
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Schonfeld Strategic Advisors LLC.

Significant Ownership of Schonfeld Strategic Advisors LLC

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
APLT Applied Therapeutics, Inc. Common Stock, par value $0.0001 per share 7.54% $4.38M 8.77M Schonfeld Strategic Advisors LLC Dec 31, 2024
TERN Terns Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share 6.16% $17.7M 5.23M Schonfeld Strategic Advisors LLC Dec 31, 2024
RVPH Reviva Pharmaceuticals Holdings, Inc. Common Stock, par value $0.0001 per share 2.82% $1.51M 1.31M Schonfeld Strategic Advisors LLC Dec 31, 2024

Schedules 13D/G Reported by Schonfeld Strategic Advisors LLC:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.